PAVmed Provides Business Update and Reports Preliminary Third Quarter 2026 Financial Results

Lucid Diagnostics' EsoGuard® now fully reimbursed by Medicare nationwideVeris Health achieved implantable physiological monitor design freeze and initiated 90-day GLP animal study ahead of early 2027 FDA submissionPAVmed engaged with FDA on PortIO and OcterisConference call and webcast to be held t…